New drug trial offers hope for Tough-to-Treat bladder cancer
NCT ID NCT07526792
Summary
This study is testing an experimental drug called SYS6002 against standard chemotherapy for people with advanced bladder cancer that has worsened after two common types of treatment. The main goal is to see if SYS6002 helps patients live longer and controls the cancer better than chemotherapy. The trial will enroll about 406 participants and is not yet open for enrollment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.